New strategies in immunotherapy for lung cancer: beyond PD-1/PD-L1

por Villanueva, Nicolas, Bazhenova, Lyudmila
Publicado 2018

Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs)

por Giustini, Nicholas, Bazhenova, Lyudmila
Publicado 2021

Update on Lorlatinib: Role in Reducing the Risk of Disease Progression in ALK-Positive NSCLC

por Yun, Karen M, Bazhenova, Lyudmila A
Publicado 2022

A Stochastic Markov Chain Model to Describe Lung Cancer Growth and Metastasis

por Newton, Paul K., Mason, Jeremy, Bethel, Kelly, Bazhenova, Lyudmila A., Nieva, Jorge, Kuhn, Peter
Publicado 2012

A Phase II study of Viagenpumatucel-l (HS-110) in combination with low-dose Cyclophosphamide versus physician's choice in patients with advanced non-small cell lung cancer

por Cohen, Roger B, Nemunaitis, John, Gabrail, Nashat, Bazhenova, Lyudmila, Schreiber, Taylor H, Price, Melissa
Publicado 2014

A Retrospective Review of the Frequency and Nature of Acute Hypersensitivity Reactions at a Medium-Sized Infusion Center: Comparison to Reported Values and Inconsistencies Found in...

por DeMoor, Patricia A., Matusov, Yuri, Kelly, Colleen, Kolan, Shobha, Barnachea, Linda, Bazhenova, Lyudmila A.
Publicado 2011

Entropy, complexity, and Markov diagrams for random walk cancer models

por Newton, Paul K., Mason, Jeremy, Hurt, Brian, Bethel, Kelly, Bazhenova, Lyudmila, Nieva, Jorge, Kuhn, Peter
Publicado 2014

Clinicopathologic and molecular characteristics of EGFR-mutant lung adenocarcinomas that transform to small cell lung cancer after TKI therapy

por Yu, Li, Bazhenova, Lyudmila, Gold, Kathryn, Tran, Lisa, Hilburn, Van, Vu, Peter, Patel, Sandip Pravin
Publicado 2022

Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer

por Shishido, Stephanie N., Carlsson, Anders, Nieva, Jorge, Bethel, Kelly, Hicks, James B., Bazhenova, Lyudmila, Kuhn, Peter
Publicado 2019

Molecular determinants of drug-specific sensitivity for epidermal growth factor receptor (EGFR) exon 19 and 20 mutants in non-small cell lung cancer

por Tsigelny, Igor F., Wheler, Jennifer J., Greenberg, Jerry P., Kouznetsova, Valentina L., Stewart, David J., Bazhenova, Lyudmila, Kurzrock, Razelle
Publicado 2015

TRK Fusion Cancer: Patient Characteristics and Survival Analysis in the Real-World Setting

por Bazhenova, Lyudmila, Lokker, Andrew, Snider, Jeremy, Castellanos, Emily, Fisher, Virginia, Fellous, Marc, Nanda, Shivani, Zong, Jihong, Keating, Karen, Jiao, Xiaolong
Publicado 2021

ALK Inhibitor Treatment Patterns and Outcomes in Real-World Patients with ALK-Positive Non-Small-Cell Lung Cancer: A Retrospective Cohort Study

por Wang, Michelle, Slatter, Shadera, Sussell, Jesse, Lin, Chia-Wei, Ogale, Sarika, Datta, Debajyoti, Butte, Atul J., Bazhenova, Lyudmila, Rudrapatna, Vivek A.
Publicado 2023

Practical Guidance for the Management of Adverse Events in Patients with KRAS(G12C)-Mutated Non-Small Cell Lung Cancer Receiving Adagrasib

por Zhang, Jun, Johnson, Melissa, Barve, Minal, Bazhenova, Lyudmila, McCarthy, Marybeth, Schwartz, Rowena, Horvath-Walsh, Elise, Velastegui, Karen, Qian, Chunlin, Spira, Alexander
Publicado 2023

Cyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristics

por Kato, Shumei, Schwaederle, Maria, Daniels, Gregory A, Piccioni, David, Kesari, Santosh, Bazhenova, Lyudmila, Shimabukuro, Kelly, Parker, Barbara A, Fanta, Paul, Kurzrock, Razelle
Publicado 2015

Frequency, underdiagnosis, and heterogeneity of epidermal growth factor receptor exon 20 insertion mutations using real‐world genomic datasets

por Viteri, Santiago, Minchom, Anna, Bazhenova, Lyudmila, Ou, Sai‐Hong Ignatius, Bauml, Joshua M., Shell, Scott A., Schaffer, Michael, Gu, Junchen, Rose, Jennifer B., Curtin, Joshua C., Mahadevia, Parthiv, Girard, Nicolas
Publicado 2022

An Observational Study of Circulating Tumor Cells and (18)F-FDG PET Uptake in Patients with Treatment-Naive Non-Small Cell Lung Cancer

por Nair, Viswam S., Keu, Khun Visith, Luttgen, Madelyn S., Kolatkar, Anand, Vasanawala, Minal, Kuschner, Ware, Bethel, Kelly, Iagaru, Andrei H., Hoh, Carl, Shrager, Joseph B., Loo, Billy W., Bazhenova, Lyudmila, Nieva, Jorge, Gambhir, Sanjiv S., Kuhn, Peter
Publicado 2013

Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology

por Patel, Sandip P., Schwaederle, Maria, Daniels, Gregory A., Fanta, Paul T., Schwab, Richard B., Shimabukuro, Kelly A., Kesari, Santosh, Piccioni, David E., Bazhenova, Lyudmila A., Helsten, Teresa L., Lippman, Scott M., Parker, Barbara A., Kurzrock, Razelle
Publicado 2015

First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors

por Bauer, Todd, Cho, Byong Chul, Heist, Rebecca, Bazhenova, Lyudmila, Werner, Theresa, Goel, Sanjay, Kim, Dong-Wan, Adkins, Douglas, Carvajal, Richard D., Alva, Ajjai, Eaton, Keith, Wang, Judy, Liu, Yong, Yan, Xiaohong, Christensen, Jamie, Neuteboom, Saskia, Chao, Richard, Pant, Shubham
Publicado 2022

First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced KRAS(G12C) Solid Tumors (KRYSTAL-1)

por Ou, Sai-Hong Ignatius, Jänne, Pasi A., Leal, Ticiana A., Rybkin, Igor I., Sabari, Joshua K., Barve, Minal A., Bazhenova, Lyudmila, Johnson, Melissa L., Velastegui, Karen L., Cilliers, Cornelius, Christensen, James G., Yan, Xiaohong, Chao, Richard C., Papadopoulos, Kyriakos P.
Publicado 2022

Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical Trial

por Gettinger, Scott N., Redman, Mary W., Bazhenova, Lyudmila, Hirsch, Fred R., Mack, Philip C., Schwartz, Lawrence H., Bradley, Jeffrey D., Stinchcombe, Thomas E., Leighl, Natasha B., Ramalingam, Suresh S., Tavernier, Susan S., Yu, Hui, Unger, Joseph M., Minichiello, Katherine, Highleyman, Louise, Papadimitrakopoulou, Vassiliki A., Kelly, Karen, Gandara, David R., Herbst, Roy S.
Publicado 2021